Professional Marketing briefs: January 2014

Share this article:
Iclusig is back in US
Iclusig is back in US

Europe's doors remain open for Ariad Pharma's leukemia drug Iclusig. PMLive reported in November that the European Medicines Agency says the drug can stay on the market, but it has restricted the patient-eligible population. The EMA said last month that it is looking closely at the drug. Ariad halted US marketing and distribution in October and is in talks with the FDA.

Bristol-MyersSquibb and AstraZeneca decided Germany can live without type 2 diabetes medication Forxiga. The companies said last month that they were pulling the drug because they can't reach a suitable pricing arrangement with insurers, reports Reuters. The announcement came the day after a US FDA panel endorsed the drug.

Forest Labs said that its cost-savings initiative—dubbed Project Rejuvenate—is aimed at reducing operating expenses by $500 million. The company said it's realigning R&D, reducing marketing expenses and slashing SG&A costs.

Eisai announced in November that it is cutting 130 jobs in the US and Europe. The Tokyo-based drugmaker said in a statement the cuts are part of its goal of “focusing and strengthening product creation capabilities.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Agency Gallery

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Agency Gallery

Agency Business briefs: June 2014

Agency Business briefs: June 2014

News on Publicis, Palio+Ignite, PulseCX, McCann HumanCare and GolinHarris

It's time to replace the FDA, says Newt Gingrich

It's time to replace the FDA, says Newt ...

Former Speaker of the House and presidential candidate Newt Gingrich has declared that it's time to replace FDA

Agency Business briefs: May 2014

Agency Business briefs: May 2014

Newson ID Media, Frontline Medical Communications and ContextMedia